19 June 2013
Keywords: merck, co, cozaar, gets, approval, stroke, prevention
Article | 31 March 2003
Merck & Co's angiotensin II receptor antagonist Cozaar (losartan) hasbecome the first and only antihypertensive to be approved in the USA ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 March 2003
7 April 2003
© 2013 thepharmaletter.com